Concepedia
Statistics
Publications
46
Citations
1.8K
H-Index
24
Active since
1993
Affiliations
Sarah Cannon(Current)
Tennessee Oncology
Florida Cancer Specialists & Research Institute
Sarah Cannon Research Institute
Oncology Hematology Care
Dana S. Thompson is an author at Sarah Cannon specializing in oncology, medicine, and chemotherapy.
Publications per year
1993–2018
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.
John D. Hainsworth, Dana S. Thompson, Filippo Greco · Journal of Clinical Oncology · 1995 · 159 citations
Medicine, Oncology, Pharmacology +10
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
F. Anthony Greco, Joan B. Erland, Lisa H. Morrissey et al. · Annals of Oncology · 2000 · 122 citations · Full text
Medicine, Oncology, Pharmacology +11
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
Johanna C. Bendell, Carla Kurkjian, Jeffrey R. Infante et al. · Investigational New Drugs · 2015 · 115 citations
Pharmacy, Oncology, Pharmacology +8
Phase II Trial of Bevacizumab and Erlotinib in Carcinomas of Unknown Primary Site: The Minnie Pearl Cancer Research Network
John D. Hainsworth, David R. Spigel, C. Farley et al. · Journal of Clinical Oncology · 2007 · 113 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin As First-Line Treatment for Patients With Metastatic Breast Cancer
Howard A. Burris, Denise A. Yardley, Suzanne F. Jones et al. · Journal of Clinical Oncology · 2004 · 99 citations
Medicine, Oncology, Pharmacology +16
1–5 of 46